Monitoring progress and managing side effects are essential components of safe use
Regulatory status: BPC-157 is not an approved human medicinal product in any regulatory zone (FDA, EMA, KL)
This cost is similar to liraglutide, 3 mg daily, which costs about $1,050 per month
Magnesium: Two forms (citrate and malate) for maximum absorption
Some common side effects encompass nausea, vomiting, diarrhea, abdominal pain, and decreased appetite
Coverage varies by plan and some of United Healthcare (UHC)s insurance plans exclude Zepbound from coverage, while other plans may cover Zepbound while requiring prior authorization before approving coverage